Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Brodix Plus - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Brodix Plus

Approved

STANDARD

Brodix Plus

MGRM Medicare Private Limited🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: 76a231b7d27bb0ac
Company: MGRM Medicare Private Limited
Type: Standard

Approval Details

Approval Id: 76a231b7d27bb0ac
Drug Approval Philippines Name: Brodix Plus
Product Name: Brodix Plus
Registration Number: DRP-4672-04
Brand Name: Brodix Plus
Generic Name: Salbutamol (as Sulfate) + lpratropium Bromide
Dosage Form: Solution For Nebulization
Dosage Strength: 2.5 mg/500 mcg per 2.5 mL
Manufacturer: MGRM Medicare Private Limited
Importer: I.E. Medica Inc
Distributor: MedEthix Inc.
Issuance Date: 24 January 2024
Expiry Date: 29 October 2028
Pharmacologic Category: Bronchodilator
Classification: Prescription Drug (RX)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

76a231b7d27bb0ac

Type

Standard

Back to Philippines FDA Approvals